Eugene

[email protected]

LATEST

United Therapeutics To Acquire Specialty Pharma Company in $216-Million Deal
By

By
United Therapeutics, a Silver Spring, Maryland-headquartered biotechnology company developing therapies for treating pulmonary arterial hypertension (PAH), has signed an agreement to acquire SteadyMed, a San Ramon, California-headquartered specialty pharmaceutical company,…

Shionogi Establishes New Mfg Subsidiary, Including Contract Mfg
By

By
Shionogi & Co., an Osaka, Japan-headquartered pharmaceutical company, says it plans to establish a new wholly owned subsidiary, effective October 1, 2018, which will be in charge of manufacturing functions…

Mylan Announces Job Cuts at Site in West Virginia
By

By
Mylan has announced layoffs affecting about 15% of its workforce at its site in Morgantown, West, Virginia, primarily in operations. Following the layoffs, Mylan said it will remain one of…

FDA Commissioner Proposes Key Priorities in Drug Pricing, Real-Time Data
By

By
During testimony before the US Senate Committee on Appropriations regarding President Trump’s fiscal year (FY) 2019 budget request, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb highlighted two of…

Zoetis To Expand Animal Vaccine Research and Manufacturing in China
By

By
Zoetis, a Shanghai, China-headquartered animal-health company spun off from Pfizer in 2013, has begun construction on a combined global manufacturing and supply and research and development (R&D) site in Suzhou,…

Novartis, Pear Therapeutics To Market Digital Therapeutics
By

By
Sandoz, Novartis’ generics arm, has partnered with Pear Therapeutics, a Boston, Massachusetts-based prescription digital therapeutics company, to commercialize Pear Therapeutics’ two lead products, reSET and reSET-O, digital therapeutics for treating…

Takeda Makes Revised Proposal for Shire for $64 Billion
By

By
Takeda offered on April 24, 2018 a revised conditional acquisition proposal to acquire Shire worth approximately $64 billion, following several rejected acquisition proposals from Takeda to Shire during March and…

Astellas Sells Certain Research Facilities to Gilead’s Kite Pharma
By

By
Astellas Pharma has transferred certain research facilities from Agensys, an affiliate of Astellas, in Santa Monica, California to Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, located in Santa Monica. The asset…

Fresenius Terminates $4.3-billion Merger with Akorn
By

By
Fresenius, a Lake Zurich, Illinois-headquartered specialty and generic pharmaceuticals company, has decided to terminate the company’s $4.3-billion merger agreement with Akorn, a Lake Forest, Illinois-headquartered specialty generic pharmaceutical company, due…

FDA Issues Complete Response Letter to Pfizer for Biosimilar of Roche’s Herceptin
By

By
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Pfizer in response to a biologics license application (BLA) for the company’s proposed biosimilar to…